dextroamphetamine has been researched along with Minimally Conscious State in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fridman, EA | 1 |
| Osborne, JR | 1 |
| Mozley, PD | 1 |
| Victor, JD | 1 |
| Schiff, ND | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Pharmacologically-induced Changes in Excitatory Glutamatergic Neurotransmission of Severe TBI Patients[NCT04244058] | Early Phase 1 | 30 participants (Anticipated) | Interventional | 2020-09-23 | Suspended (stopped due to Given CoVid-19 pandemic we could not recruit subjects/patients for the 1st year. Currently waiting for new sponsor to fulfill the aims.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for dextroamphetamine and Minimally Conscious State
| Article | Year |
|---|---|
Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.
Topics: Adult; Brain Injuries, Traumatic; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Plasma Memb | 2019 |